Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
JCO Oncology Practice|January 14, 2026
Quality Matters: Linking Patterns of Care to Ovarian Cancer Survival in a National Gynae-Oncology RegistryMahendra Naidoo, Orla McNally, Clare L Scott, et al.
BMJ Open|August 31, 2017
Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot studyPaul A Cohen, Alison Brand, Peter Sykes, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|July 23, 2025
What Happens After Menopause (WHAM)? A Progress Report of a Prospective Controlled Study of Women After Pre-Menopausal Risk-Reducing Bilateral Salpingo-OophorectomySarah A L Price, Pauline M Maki, Samar R El Khoudary, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2025
Patterns of care and development of quality indicators in patients with non-epithelial and rare ovarian tumors in Australia: insights from the National Gynae-Oncology RegistryYeh Chen Lee, Aleesha Whitely, Michael Burling, et al.
Gynecologic Oncology|March 1, 2019
Pathological process has a crucial role in sentinel node biopsy for vulvar cancerPeter Sykes, Lois Eva, Rachael van der Griend, et al.
Plos One|March 23, 2011
Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesisCatherine Emmanuel, Natalie Gava, Catherine Kennedy, et al.
Gynecologic Oncology|August 21, 2017
Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counsellingSharon E Johnatty, Yen Y Tan, Daniel D Buchanan, et al.
BMJ Open|April 13, 2023
Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trialSandra Hayes, Andreas Obermair, Linda Mileshkin, et al.
British Journal of Cancer|November 28, 2019
FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancerStephanie Annett, Gillian Moore, Amy Short, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driverCatherine Emmanuel, Yoke-Eng Chiew, Joshy George, et al.
Pageof 7